Loading…

Novel iodinated gold nanoclusters for precise diagnosis of thyroid cancerElectronic supplementary information (ESI) available. See DOI: 10.1039/c6nr07656d

As the most common endocrine malignancy with a high incidence, thyroid cancer lacks a dual-modal imaging method for precise diagnosis. An accurate and multimodal imaging system is pivotal to solve this problem. Herein, dual-modality fluorescence/Computed Tomography (CT) iodinated gold nanoclusters f...

Full description

Saved in:
Bibliographic Details
Main Authors: Chen, Xin, Zhu, Huanhuan, Huang, Xin, Wang, Peisong, Zhang, Fulei, Li, Wei, Chen, Guang, Chen, Bingdi
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 2231
container_issue 6
container_start_page 2219
container_title
container_volume 9
creator Chen, Xin
Zhu, Huanhuan
Huang, Xin
Wang, Peisong
Zhang, Fulei
Li, Wei
Chen, Guang
Chen, Bingdi
description As the most common endocrine malignancy with a high incidence, thyroid cancer lacks a dual-modal imaging method for precise diagnosis. An accurate and multimodal imaging system is pivotal to solve this problem. Herein, dual-modality fluorescence/Computed Tomography (CT) iodinated gold nanoclusters for malignant thyroid cancer visualization have been recently fabricated. In this study, innovative iodinated gold nanoclusters (AuNCs@BSA-I) were synthesized via Bovine serum albumin (BSA) and chloramine-T. AuNCs@BSA-I not only possess an ultra-small size and brilliant biocompatibility but also exhibit excellent fluorescence/CT imaging properties. Particularly with regard to CT imaging properties, AuNCs@BSA-I rival the clinical CT contrast medium. And the fluorescence emission spectrum of AuNCs@BSA-I falls in the near infrared region (NIR). For further translational application in medicine, we established an orthotopic human thyroid cancer patient tissue derived xenograft (PDX) mouse model, highly close to the actual human thyroid cancer. The results unveil that AuNCs@BSA-I exert sensitive and accurate diagnosis characteristics. To be more specific, the AuNCs@BSA-I fluorescent/CT signals in the thyroid tumor represent characteristics of 'slow in fast out', compared to those in the normal thyroid. Moreover, AuNCs@BSA-I could distinguish minimal thyroid cancer, as small as 2 mm 3 . Therefore, AuNCs@BSA-I appear to be a promising nanoprobe which could be applied to preclinical medicine. Novel iodinated gold nanoclusters have been fabricated, whose fluorescent/CT signals in the thyroid cancer are distinguishable to those in the normal thyroid, representing a promising nanoprobe for precise diagnosis of thyroid cancer.
doi_str_mv 10.1039/c6nr07656d
format article
fullrecord <record><control><sourceid>rsc</sourceid><recordid>TN_cdi_rsc_primary_c6nr07656d</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>c6nr07656d</sourcerecordid><originalsourceid>FETCH-rsc_primary_c6nr07656d3</originalsourceid><addsrcrecordid>eNqFjzFLQzEUhYMoWKuLu3DddGhNm5pSV31ilzrU_RGT--qVvORxb1roX_HX2qHoINjpHDgfHxylLkd6ONJmdudtYj219zYcqd5YT_TAmOn4-Kfbyak6E_nU2s6MNT31tcgbjEA5UHIFA6xyDJBcyj6upSALNJmhY_QkCIHcKmUhgdxA-dhypgDeJY9cRfSFcyIPsu66iC2m4ngLlHaG1hXKCW6q5fwW3MZRdO8Rh7BEhKfX-QP8fXCuThoXBS_22VdXz9Xb48uAxdcdU7uT17-46avr__a6C4055PgGrUNlpw</addsrcrecordid><sourcetype>Enrichment Source</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Novel iodinated gold nanoclusters for precise diagnosis of thyroid cancerElectronic supplementary information (ESI) available. See DOI: 10.1039/c6nr07656d</title><source>Royal Society of Chemistry</source><creator>Chen, Xin ; Zhu, Huanhuan ; Huang, Xin ; Wang, Peisong ; Zhang, Fulei ; Li, Wei ; Chen, Guang ; Chen, Bingdi</creator><creatorcontrib>Chen, Xin ; Zhu, Huanhuan ; Huang, Xin ; Wang, Peisong ; Zhang, Fulei ; Li, Wei ; Chen, Guang ; Chen, Bingdi</creatorcontrib><description>As the most common endocrine malignancy with a high incidence, thyroid cancer lacks a dual-modal imaging method for precise diagnosis. An accurate and multimodal imaging system is pivotal to solve this problem. Herein, dual-modality fluorescence/Computed Tomography (CT) iodinated gold nanoclusters for malignant thyroid cancer visualization have been recently fabricated. In this study, innovative iodinated gold nanoclusters (AuNCs@BSA-I) were synthesized via Bovine serum albumin (BSA) and chloramine-T. AuNCs@BSA-I not only possess an ultra-small size and brilliant biocompatibility but also exhibit excellent fluorescence/CT imaging properties. Particularly with regard to CT imaging properties, AuNCs@BSA-I rival the clinical CT contrast medium. And the fluorescence emission spectrum of AuNCs@BSA-I falls in the near infrared region (NIR). For further translational application in medicine, we established an orthotopic human thyroid cancer patient tissue derived xenograft (PDX) mouse model, highly close to the actual human thyroid cancer. The results unveil that AuNCs@BSA-I exert sensitive and accurate diagnosis characteristics. To be more specific, the AuNCs@BSA-I fluorescent/CT signals in the thyroid tumor represent characteristics of 'slow in fast out', compared to those in the normal thyroid. Moreover, AuNCs@BSA-I could distinguish minimal thyroid cancer, as small as 2 mm 3 . Therefore, AuNCs@BSA-I appear to be a promising nanoprobe which could be applied to preclinical medicine. Novel iodinated gold nanoclusters have been fabricated, whose fluorescent/CT signals in the thyroid cancer are distinguishable to those in the normal thyroid, representing a promising nanoprobe for precise diagnosis of thyroid cancer.</description><identifier>ISSN: 2040-3364</identifier><identifier>EISSN: 2040-3372</identifier><identifier>DOI: 10.1039/c6nr07656d</identifier><language>eng</language><creationdate>2017-02</creationdate><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Chen, Xin</creatorcontrib><creatorcontrib>Zhu, Huanhuan</creatorcontrib><creatorcontrib>Huang, Xin</creatorcontrib><creatorcontrib>Wang, Peisong</creatorcontrib><creatorcontrib>Zhang, Fulei</creatorcontrib><creatorcontrib>Li, Wei</creatorcontrib><creatorcontrib>Chen, Guang</creatorcontrib><creatorcontrib>Chen, Bingdi</creatorcontrib><title>Novel iodinated gold nanoclusters for precise diagnosis of thyroid cancerElectronic supplementary information (ESI) available. See DOI: 10.1039/c6nr07656d</title><description>As the most common endocrine malignancy with a high incidence, thyroid cancer lacks a dual-modal imaging method for precise diagnosis. An accurate and multimodal imaging system is pivotal to solve this problem. Herein, dual-modality fluorescence/Computed Tomography (CT) iodinated gold nanoclusters for malignant thyroid cancer visualization have been recently fabricated. In this study, innovative iodinated gold nanoclusters (AuNCs@BSA-I) were synthesized via Bovine serum albumin (BSA) and chloramine-T. AuNCs@BSA-I not only possess an ultra-small size and brilliant biocompatibility but also exhibit excellent fluorescence/CT imaging properties. Particularly with regard to CT imaging properties, AuNCs@BSA-I rival the clinical CT contrast medium. And the fluorescence emission spectrum of AuNCs@BSA-I falls in the near infrared region (NIR). For further translational application in medicine, we established an orthotopic human thyroid cancer patient tissue derived xenograft (PDX) mouse model, highly close to the actual human thyroid cancer. The results unveil that AuNCs@BSA-I exert sensitive and accurate diagnosis characteristics. To be more specific, the AuNCs@BSA-I fluorescent/CT signals in the thyroid tumor represent characteristics of 'slow in fast out', compared to those in the normal thyroid. Moreover, AuNCs@BSA-I could distinguish minimal thyroid cancer, as small as 2 mm 3 . Therefore, AuNCs@BSA-I appear to be a promising nanoprobe which could be applied to preclinical medicine. Novel iodinated gold nanoclusters have been fabricated, whose fluorescent/CT signals in the thyroid cancer are distinguishable to those in the normal thyroid, representing a promising nanoprobe for precise diagnosis of thyroid cancer.</description><issn>2040-3364</issn><issn>2040-3372</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqFjzFLQzEUhYMoWKuLu3DddGhNm5pSV31ilzrU_RGT--qVvORxb1roX_HX2qHoINjpHDgfHxylLkd6ONJmdudtYj219zYcqd5YT_TAmOn4-Kfbyak6E_nU2s6MNT31tcgbjEA5UHIFA6xyDJBcyj6upSALNJmhY_QkCIHcKmUhgdxA-dhypgDeJY9cRfSFcyIPsu66iC2m4ngLlHaG1hXKCW6q5fwW3MZRdO8Rh7BEhKfX-QP8fXCuThoXBS_22VdXz9Xb48uAxdcdU7uT17-46avr__a6C4055PgGrUNlpw</recordid><startdate>20170209</startdate><enddate>20170209</enddate><creator>Chen, Xin</creator><creator>Zhu, Huanhuan</creator><creator>Huang, Xin</creator><creator>Wang, Peisong</creator><creator>Zhang, Fulei</creator><creator>Li, Wei</creator><creator>Chen, Guang</creator><creator>Chen, Bingdi</creator><scope/></search><sort><creationdate>20170209</creationdate><title>Novel iodinated gold nanoclusters for precise diagnosis of thyroid cancerElectronic supplementary information (ESI) available. See DOI: 10.1039/c6nr07656d</title><author>Chen, Xin ; Zhu, Huanhuan ; Huang, Xin ; Wang, Peisong ; Zhang, Fulei ; Li, Wei ; Chen, Guang ; Chen, Bingdi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-rsc_primary_c6nr07656d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Chen, Xin</creatorcontrib><creatorcontrib>Zhu, Huanhuan</creatorcontrib><creatorcontrib>Huang, Xin</creatorcontrib><creatorcontrib>Wang, Peisong</creatorcontrib><creatorcontrib>Zhang, Fulei</creatorcontrib><creatorcontrib>Li, Wei</creatorcontrib><creatorcontrib>Chen, Guang</creatorcontrib><creatorcontrib>Chen, Bingdi</creatorcontrib></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Xin</au><au>Zhu, Huanhuan</au><au>Huang, Xin</au><au>Wang, Peisong</au><au>Zhang, Fulei</au><au>Li, Wei</au><au>Chen, Guang</au><au>Chen, Bingdi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel iodinated gold nanoclusters for precise diagnosis of thyroid cancerElectronic supplementary information (ESI) available. See DOI: 10.1039/c6nr07656d</atitle><date>2017-02-09</date><risdate>2017</risdate><volume>9</volume><issue>6</issue><spage>2219</spage><epage>2231</epage><pages>2219-2231</pages><issn>2040-3364</issn><eissn>2040-3372</eissn><abstract>As the most common endocrine malignancy with a high incidence, thyroid cancer lacks a dual-modal imaging method for precise diagnosis. An accurate and multimodal imaging system is pivotal to solve this problem. Herein, dual-modality fluorescence/Computed Tomography (CT) iodinated gold nanoclusters for malignant thyroid cancer visualization have been recently fabricated. In this study, innovative iodinated gold nanoclusters (AuNCs@BSA-I) were synthesized via Bovine serum albumin (BSA) and chloramine-T. AuNCs@BSA-I not only possess an ultra-small size and brilliant biocompatibility but also exhibit excellent fluorescence/CT imaging properties. Particularly with regard to CT imaging properties, AuNCs@BSA-I rival the clinical CT contrast medium. And the fluorescence emission spectrum of AuNCs@BSA-I falls in the near infrared region (NIR). For further translational application in medicine, we established an orthotopic human thyroid cancer patient tissue derived xenograft (PDX) mouse model, highly close to the actual human thyroid cancer. The results unveil that AuNCs@BSA-I exert sensitive and accurate diagnosis characteristics. To be more specific, the AuNCs@BSA-I fluorescent/CT signals in the thyroid tumor represent characteristics of 'slow in fast out', compared to those in the normal thyroid. Moreover, AuNCs@BSA-I could distinguish minimal thyroid cancer, as small as 2 mm 3 . Therefore, AuNCs@BSA-I appear to be a promising nanoprobe which could be applied to preclinical medicine. Novel iodinated gold nanoclusters have been fabricated, whose fluorescent/CT signals in the thyroid cancer are distinguishable to those in the normal thyroid, representing a promising nanoprobe for precise diagnosis of thyroid cancer.</abstract><doi>10.1039/c6nr07656d</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2040-3364
ispartof
issn 2040-3364
2040-3372
language eng
recordid cdi_rsc_primary_c6nr07656d
source Royal Society of Chemistry
title Novel iodinated gold nanoclusters for precise diagnosis of thyroid cancerElectronic supplementary information (ESI) available. See DOI: 10.1039/c6nr07656d
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T03%3A53%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-rsc&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20iodinated%20gold%20nanoclusters%20for%20precise%20diagnosis%20of%20thyroid%20cancerElectronic%20supplementary%20information%20(ESI)%20available.%20See%20DOI:%2010.1039/c6nr07656d&rft.au=Chen,%20Xin&rft.date=2017-02-09&rft.volume=9&rft.issue=6&rft.spage=2219&rft.epage=2231&rft.pages=2219-2231&rft.issn=2040-3364&rft.eissn=2040-3372&rft_id=info:doi/10.1039/c6nr07656d&rft_dat=%3Crsc%3Ec6nr07656d%3C/rsc%3E%3Cgrp_id%3Ecdi_FETCH-rsc_primary_c6nr07656d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true